Product NDC: | 0173-0352 |
Proprietary Name: | ZINACEF |
Non Proprietary Name: | cefuroxime |
Active Ingredient(s): | 750 mg/8.3mL & nbsp; cefuroxime |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0352 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050558 |
Marketing Category: | NDA |
Start Marketing Date: | 20041124 |
Package NDC: | 0173-0352-10 |
Package Description: | 10 VIAL in 1 TRAY (0173-0352-10) > 8.3 mL in 1 VIAL |
NDC Code | 0173-0352-10 |
Proprietary Name | ZINACEF |
Package Description | 10 VIAL in 1 TRAY (0173-0352-10) > 8.3 mL in 1 VIAL |
Product NDC | 0173-0352 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cefuroxime |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20041124 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | CEFUROXIME SODIUM |
Strength Number | 750 |
Strength Unit | mg/8.3mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |